BiotechTubeBiotechTube
Home/Pipeline/Oncology APIs (e.g., Sorafenib, Lenalidomide)

Oncology APIs (e.g., Sorafenib, Lenalidomide)

Various Cancers

Commercial/FiledActive

Key Facts

Indication
Various Cancers
Phase
Commercial/Filed
Status
Active
Company
Laurus Labs

About Laurus Labs

Laurus Labs is a vertically integrated pharmaceutical company based in Hyderabad, India, with a significant global presence in the API and generic formulations market. It has established itself as a key player in the global supply of HIV/AIDS drugs and has strategically expanded into high-growth areas like oncology, cardiology, and diabetes. The company leverages its strong R&D and manufacturing capabilities to serve both regulated and emerging markets, with a growing CDMO business catering to innovator companies worldwide.

View full company profile

Therapeutic Areas

HIV/AIDSOncologyCardiovascularMetabolic DisordersCentral Nervous System

Other Various Cancers Drugs

DrugCompanyPhase
RetifanlimabEli LillyPhase 2/3
Imfinzi (durvalumab)AstraZenecaApproved
Lynparza (olaparib)MerckCommercial
Oncology PortfolioPfizerPhase 1-3
PD-1 InhibitorAkesoPhase 2/3
Mitoxantrone LiposomeCSPC Pharmaceutical Group LimitedPhase 3
Biosimilar BevacizumabCiplaCommercial
Tazverik (tazemetostat)EisaiCommercial
Oncology GenericsAurobindo PharmaCommercial
Opdivo (nivolumab)Ono PharmaceuticalApproved
Tumor Marker Portfolio (PSA, CA125, etc.)H.U. Group HoldingsCommercial
Logic-gated Switch-DARPinsMolecular PartnersPreclinical